PURPOSE: Exercise is associated with a decrease in bone mineral density under certain conditions. One potential mechanism is increased bone resorption due to an exercise-induced increase in parathyroid hormone (PTH), possibly triggered by dermal calcium loss. The purpose of this investigation was to determine whether calcium supplementation either before or during exercise attenuates exercise-induced increases in PTH and C-terminal telopeptide of TypeI collagen (CTX; a marker of bone resorption). METHODS:Male endurance athletes (n = 20) completed three 35-km cycling time trials under differing calcium supplementation conditions: 1) 1000 mg of calcium 20 min before exercise and placebo during, 2) placebo before and 250 mg of calcium every 15 min during exercise (1000 mg total), or 3) placebo before and during exercise. Calcium was delivered in a 1000-mg·L(-1) solution. Supplementation was double-blinded, and trials were performed in random order. PTH, CTX, bone-specific alkaline phosphatase (BAP; a marker of bone formation), and ionized calcium (iCa) were measured before and immediately after exercise. RESULTS:CTX increased and iCa decreased similarly in response to exercise under all test conditions. When compared with placebo, calcium supplementation before exercise attenuated the increase in PTH (mean ± SE: 55.8 ± 15.0 vs 74.0 ± 14.2 pg·mL(-1), P = 0.04); there was a similar trend (58.0 ± 17.4, P = 0.07) for calcium supplementation during exercise. There were no effects of calcium on changes in CTX, BAP, and iCa. CONCLUSIONS:Calcium supplementation before exercise attenuated the disruption of PTH. Further research is needed to determine the effects of repeated increases in PTH and CTX on bone (i.e., exercise training) and whether calcium supplementation can diminish any exercise-induced demineralization.
RCT Entities:
PURPOSE: Exercise is associated with a decrease in bone mineral density under certain conditions. One potential mechanism is increased bone resorption due to an exercise-induced increase in parathyroid hormone (PTH), possibly triggered by dermal calcium loss. The purpose of this investigation was to determine whether calcium supplementation either before or during exercise attenuates exercise-induced increases in PTH and C-terminal telopeptide of Type I collagen (CTX; a marker of bone resorption). METHODS: Male endurance athletes (n = 20) completed three 35-km cycling time trials under differing calcium supplementation conditions: 1) 1000 mg of calcium 20 min before exercise and placebo during, 2) placebo before and 250 mg of calcium every 15 min during exercise (1000 mg total), or 3) placebo before and during exercise. Calcium was delivered in a 1000-mg·L(-1) solution. Supplementation was double-blinded, and trials were performed in random order. PTH, CTX, bone-specific alkaline phosphatase (BAP; a marker of bone formation), and ionizedcalcium (iCa) were measured before and immediately after exercise. RESULTS:CTX increased and iCa decreased similarly in response to exercise under all test conditions. When compared with placebo, calcium supplementation before exercise attenuated the increase in PTH (mean ± SE: 55.8 ± 15.0 vs 74.0 ± 14.2 pg·mL(-1), P = 0.04); there was a similar trend (58.0 ± 17.4, P = 0.07) for calcium supplementation during exercise. There were no effects of calcium on changes in CTX, BAP, and iCa. CONCLUSIONS:Calcium supplementation before exercise attenuated the disruption of PTH. Further research is needed to determine the effects of repeated increases in PTH and CTX on bone (i.e., exercise training) and whether calcium supplementation can diminish any exercise-induced demineralization.
Authors: R C Klesges; K D Ward; M L Shelton; W B Applegate; E D Cantler; G M Palmieri; K Harmon; J Davis Journal: JAMA Date: 1996-07-17 Impact factor: 56.272
Authors: N Kitamura; C Shigeno; K Shiomi; K Lee; S Ohta; T Sone; S Katsushima; E Tadamura; T Kousaka; I Yamamoto Journal: J Clin Endocrinol Metab Date: 1990-01 Impact factor: 5.958
Authors: Sundeep Khosla; Teresita M Bellido; Marc K Drezner; Catherine M Gordon; Tamara B Harris; Douglas P Kiel; Barbara E Kream; Meryl S LeBoff; Jane B Lian; Charlotte A Peterson; Clifford J Rosen; John P Williams; Karen K Winer; Sherry S Sherman Journal: J Bone Miner Res Date: 2011-09-13 Impact factor: 6.741
Authors: Wendy M Kohrt; Sarah J Wherry; Pamela Wolfe; Vanessa D Sherk; Toby Wellington; Christine M Swanson; Connie M Weaver; Rebecca S Boxer Journal: J Bone Miner Res Date: 2018-04-18 Impact factor: 6.741
Authors: Vanessa D Sherk; Sarah J Wherry; Daniel W Barry; Karen L Shea; Pamela Wolfe; Wendy M Kohrt Journal: Med Sci Sports Exerc Date: 2017-07 Impact factor: 5.411
Authors: Sarah J Wherry; Christine M Swanson; Pamela Wolfe; Toby Wellington; Rebecca S Boxer; Robert S Schwartz; Wendy M Kohrt Journal: Med Sci Sports Exerc Date: 2019-08 Impact factor: 5.411
Authors: Wendy M Kohrt; Pamela Wolfe; Vanessa D Sherk; Sarah J Wherry; Toby Wellington; Edward L Melanson; Christine M Swanson; Connie M Weaver; Rebecca S Boxer Journal: Med Sci Sports Exerc Date: 2019-10 Impact factor: 5.411
Authors: Vanessa D Sherk; Daniel W Barry; Karen L Villalon; Kent C Hansen; Pamela Wolfe; Wendy M Kohrt Journal: Clin J Sport Med Date: 2014-07 Impact factor: 3.638
Authors: Karen L Shea; Daniel W Barry; Vanessa D Sherk; Kent C Hansen; Pamela Wolfe; Wendy M Kohrt Journal: Med Sci Sports Exerc Date: 2014-10 Impact factor: 5.411
Authors: Laura J Lutz; J Philip Karl; Jennifer C Rood; Sonya J Cable; Kelly W Williams; Andrew J Young; James P McClung Journal: J Int Soc Sports Nutr Date: 2012-08-06 Impact factor: 5.150
Authors: Hugo Olmedillas; Alejandro González-Agüero; Luis A Moreno; José A Casajus; Germán Vicente-Rodríguez Journal: BMC Med Date: 2012-12-20 Impact factor: 8.775